MAM
NVLN

Meeder Asset Management’s Novelion Therapeutics Inc. Common Shares NVLN Stock Holding History

Meeder Asset Management’s Portfolio NVLN Stock Details NVLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-3,159
Closed -$9K – 1876
2018
Q3 		$9K Buy
3,159
+2,495
+376% +$7.11K ﹤0.01% 1200
2018
Q2 		$2.44K Hold
664
– – ﹤0.01% 1394
2018
Q1 		$2K Sell
664
-100
-13% -$301 ﹤0.01% 1427
2017
Q4 		$2K Buy
+764
New +$2K ﹤0.01% 1534